SGLT2 Inhibitors and Pulmonary Arterial Hypertension: A Retrospective Study

被引：0
|
作者：
Abu-Rmaileh, M. [1 ]
Abu-Rmaileh, M. [1 ]
Hardin, E. [2 ]
Shah, T. [1 ]
Chin, K. M. [3 ]
机构：
[1] UTSW, Internal Med, Dallas, TX USA
[2] UTSW, Cardiol, Dallas, TX USA
[3] UT SouthWestern, Dallas, TX USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6119
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Further insights into SGLT2 inhibitors
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (01) : 2 - 2
  • [42] SGLT2 Inhibitors and Euglycemic Ketoacidosis
    Masuta, Pardeep
    Johri, Geetanjali
    Paul, Manju
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (04) : E498 - E500
  • [43] Targeting senescence with SGLT2 inhibitors
    Le Bras, Alexandra
    LAB ANIMAL, 2024, 53 (07) : 176 - 176
  • [44] An update on the safety of SGLT2 inhibitors
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (04) : 295 - 311
  • [45] SGLT2 Inhibitors and the Diabetic Kidney
    Fioretto, Paola
    Zambon, Alberto
    Rossato, Marco
    Busetto, Luca
    Vettor, Roberto
    DIABETES CARE, 2016, 39 : S165 - S171
  • [46] Cancer: Repurposing SGLT2 inhibitors
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2019, 18 (1) : 18 - 18
  • [47] Chances and risks of SGLT2 inhibitors
    Peter Mayer
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 551 - 554
  • [48] SGLT2 Inhibitors in Liver Patients
    Hsiang, John Chen
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2168 - +
  • [49] Cardiovascular benefit of SGLT2 inhibitors
    Mohebi, Reza
    Januzzi, James L.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (03) : 142 - 155
  • [50] Diabetic ketoacidosis with SGLT2 inhibitors
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
12345